HGF, IGF1 and VEGFA play central roles in protecting against hepatic damage under hepatic I/R conditions [53,54,55,56,57] and some of these growth factors are being tested in clinical trials, for instance on patients with liver failure [58]. Here, IGF1 is linked to liver failure.